NCI Approves John Theurer Cancer Center as Member of Research Consortium   

NCI Approves John Theurer Cancer Center as Member of Research Consortium

John Theurer Cancer Center recently announced it received approval from the National Cancer Institute as a research consortium member of the NCI-approved Georgetown Lombardi Comprehensive Cancer Center Consortium. John Theurer Cancer Center is now a member of one of just 16 NCI-recognized cancer consortia based at the nation’s most prestigious institutions including Harvard University, Dana-Farber/ Harvard Cancer Center; Cleveland Clinic, part of the NCI-designated Case Comprehensive Cancer Center and the Mayo Clinic Cancer Center. John Theurer Cancer Center’s collaboration with NCI-designated Georgetown Lombardi Comprehensive Cancer Center enables both organizations to continue their research at the highest level to deliver tomorrow’s breakthroughs in cancer cures.

READ FULL ARTICLE ON ASCO

We use cookies to improve your experience. Please read our Privacy Policy or click Accept.
X